Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the Bode Review topic
No spam. Unsubscribe anytime.
Commission tables Bode‑related self‑disclosure while vendor completes Texas review of 328 cases
Summary
Staff said a Bode review of 328 Texas cases (Jan 2024–Apr 2026) has identified five potentially impacted cases; commissioners tabled the self‑disclosure until the vendor completes its Texas‑specific review and returns in October.
Commission staff briefed members on a self‑disclosure tied to vendor casework and testimony in complex DNA mixture matters. Staff reported that Bode has begun a Texas‑specific retrospective review of 328 cases between January 2024 and April 2026 and has preliminarily identified five cases that may be affected; staff recommended tabling final disposition until that review is complete.
"Bode has...started their review of Texas related case work, which really applies to, the DPS cap lab, for the prior 2 years to identify potentially impacted cases of 328 total cases between January 2024 and April 2026. They've identified 5 cases that potentially fit into this complex DNA mixture...issue," a presenter said while describing corrective actions already taken by the vendor. Commissioners voted to table the item and asked staff to report vendor findings at the October meeting. The motion to table carried on a voice vote.
Why it matters: a vendor review that spans hundreds of cases can affect criminal convictions, pending appeals, and public confidence in forensic results. The commission did not make a final factual finding; its decision was procedural—waiting for the vendor’s completed review before taking additional administrative or investigatory steps.
